• 1
    Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes ?A3B2 thyc?> in the US population in 1988-1994 and 2005-2006. Diabetes Care 2009;32:287-294.
  • 2
    Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000;49:677-683.
  • 3
    Faerch K, Vaag A. Metabolic inflexibility is a common feature of impaired fasting glycaemia and impaired glucose tolerance. Acta Diabetol 2011;48:349-353.
  • 4
    Coyle EF. Substrate utilization during exercise in active people. Am J Clin Nutr 1995;61:968S-979S.
  • 5
    Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc 1995;27:875-881.
  • 6
    Colberg SR, Hagberg JM, McCole SD, Zmuda JM, Thompson PD, Kelley DE. Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise. J Appl Physiol 1996;81(5):20272033.
  • 7
    Geerling BJ, Alles MS, Murgatroyd PR, Goldberg GR, Harding M, Prentice AM. Fatness in relation to substrate oxidation during exercise. Int J Obes Relat Metab Disord 1994;18(7):453-459.
  • 8
    Goodpaster BH, Wolfe RR, Kelley DE. Effects of obesity on substrate utilization during exercise. Obes Res 2002;10(7):575-584.
  • 9
    Hickner RC, Privette J, McIver K, Barakat H. Fatty acid oxidation in African-American and Caucasian women during physical activity. J Appl Physiol 2001;90(6):2319-2324.
  • 10
    Braun B, Sharoff C, Chipkin SR, Beaudoin F. Effects of insulin resistance on substrate utilization during exercise in overweight women. J Appl Physiol 2004;97(3):991-997.
  • 11
    Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2007;114(1):82-96.
  • 12
    Prior SJ, Joseph LJ, Brandauer J, Katzel LI, Hagberg JM, Ryan AS. Reduction in midthigh low-density muscle with aerobic exercise training and weight loss impacts glucose tolerance in older men. J Clin Endocrinol Metab 2007;92(3):880-886.
  • 13
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412-419.
  • 14
    Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22(9):1462-1470.
  • 15
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35:S64-S71.
  • 16
    Andres R, Swerdloff RS, Pozefsky T, Coleman D. Manual feedback technique for the control of blood glucose concentration. Scova N. et al. In Automation in Analytical Chemistry (Technicon Symposium). New York: Mediad; 1966, 489-491.
  • 17
    DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
  • 18
    Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949;109:1-9.
  • 19
    Kelley DE. Skeletal muscle fat oxidation: timing and flexibility are everything. J Clin Invest 2005;115:1699-1702.
  • 20
    Galgani JE, Heilbronn LK, Azuma K, et al. Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes 2008;57(4):841-845.
  • 21
    Russell RD, Kraemer RR, Nelson AG. Metabolic dysfunction in diabetic offspring: deviations in metabolic flexibility. Med Sci Sports Exerc 2013;45:8-15.
  • 22
    Numao S, Hayashi Y, Katayama Y, Matsuo T, Tanaka K. Sex differences in substrate oxidation during aerobic exercise in obese men and postmenopausal obese women. Metabolism 2009;58:1312-1319.
  • 23
    Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 2000;49:2102-2107.
  • 24
    Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 2001;50:2548-2554.
  • 25
    Prior SJ, McKenzie MJ, Joseph LJ, et al. Reduced skeletal muscle capillarization and glucose intolerance. Microcirculation 2009;16:203-212.
  • 26
    Prior SJ, Ryan AS. Low clonogenic potential of circulating angiogenic cells is associated with lower density of capillaries in skeletal muscle capillarization in patients with impaired glucose tolerance. Diabetes Metab Res Rev 2013;29:319-325.
  • 27
    Hespel P, Vergauwen L, Vandenberghe K, Richter EA. Important role of insulin and flow in stimulating glucose uptake in contracting skeletal muscle. Diabetes 1995;44:210-215.
  • 28
    Vollus GC, Bradley EA, Roberts |MK, et al. Graded occlusion of perfused rat muscle vasculature decreases insulin action. Clin Sci (Lond) 2007;112:457-466.
  • 29
    Martin IK, Katz A, Wahren J. Splanchnic and muscle metabolism during exercise in NIDDM patients. Am J Physiol 1995;269:E583-E590.
  • 30
    Ho RC, Hirshman MF, Li Y, et al. Regulation of IkappaB kinase and NF-kappaB in contracting adult rat skeletal muscle. Am J Physiol Cell Physiol 2005;289:C794-C801.
  • 31
    Phillips DI, Caddy S, Ilic V, et al. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 1996;45:947-950.
  • 32
    Krssak M, Falk PK, Dresner A, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42:113-116.
  • 33
    Bogardus C, Lillioja S, Stone K, Mott D. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 1984;73:1185-1190.
  • 34
    Levin K, Daa SH, Alford FP, Beck-Nielsen H. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia 2001;44:824-833.
  • 35
    Galgani JE, Moro C, Ravussin E. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 2008;295:E1009-E1017.
  • 36
    Morino K, Petersen KF, Dufour S, et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 2005;115:3587-3593.
  • 37
    Kulkarni SS, Salehzadeh F, Fritz T, Zierath JR, Krook A, Osler ME. Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus. Metabolism 2012;61:175-185.
  • 38
    Constantin-Teodosiu D, Constantin D, Stephens F, Laithwaite D, Greenhaff PL. The role of FOXO and PPAR transcription factors in diet-mediated inhibition of PDC activation and carbohydrate oxidation during exercise in humans and the role of pharmacological activation of PDC in overriding these changes. Diabetes 2012;61:1017-1024.
  • 39
    Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
  • 40
    Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.